Vranov, Czechia

Petr Kanovsky

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fakultni Nemocnice Olomouc, Univerzita Palackeho. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petr Kanovsky. Retrieved from https://idiyas.com/inventor/petr-kanovsky-clw3n5m0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petr Kanovsky: Innovator in Neuroprotection

Introduction

Petr Kanovsky is a notable inventor based in Vranov, Czech Republic. He has made significant contributions to the field of neuroprotection through his innovative research and development of pharmaceutical compounds. His work focuses on addressing neurodegenerative diseases, particularly Parkinson's disease.

Latest Patents

Petr Kanovsky holds a patent for "Heterocyclic nitrogen-containing purine derivatives, pharmaceutical preparations containing these derivatives and their use in neuroprotection." This patent discloses a new generation of compounds that possess selective antineurodegenerative properties on neuronal cells and tissues. These compounds can be particularly useful in the treatment and prophylaxis of neurodegenerative diseases, especially Parkinson's disease.

Career Highlights

Throughout his career, Petr Kanovsky has worked with esteemed institutions such as Palacký University and Faculty Hospital Olomouc. His research has contributed to advancements in the understanding and treatment of neurodegenerative conditions.

Collaborations

Petr has collaborated with notable colleagues, including Gabriel Gonzales and Václav Mik. Their combined expertise has furthered the development of innovative solutions in the field of neuroprotection.

Conclusion

Petr Kanovsky's contributions to neuroprotection through his patented innovations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…